|
|
CORPORATE RESULTS
PHARMACEUTICALS
Glenmark Q4 net up; to pay Rs 6 per share
BUOYED by sales of its new products Esoz and Glevo, Glenmark Pharmaceuticals Ltd has almost doubled its net profit for the quarter ended March 31, 2002, to Rs 6.76 crore (Rs 3.45 crore). A deferred tax liability of about Rs 1 crore in the ...
More
INTERNET
Rediff revenues up 340 per cent: Net loss at $14.75 million
Revenues grew 340 per cent during the year, amounting to $24.76 million ($5.62 million). Operating expenses declined 21 per cent, to $2.68 million.
More
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
Top Stories
Calcutta HC alters stay on jute packaging order
Guindy estate: Mirroring the decline of SSIs
ATM spree: Street-corner banking is here to stay
Plea to remove farm sector from WTO purview
Rly Ministry keen on viability
Urea policy approved: Net impact on industry at Rs 1,033 cr
No war — at least for now
Rediff revenues up 340 per cent: Net loss at $14.75 million
In Depth
Inside Kashmir
Guide to derivatives
US-64
Looking back
May. 5-May. 11
Ashok Leyland net rises marginally -- Steps up dividend to Rs 4.50
|
